跳至主要内容
临床试验/NL-OMON51373
NL-OMON51373已完成2 期

The immunomodulatory effect of sugammadex after total hip replacement surgery under neuraxial anaesthesia: a pilot study - MAGIC study

Radboud Universitair Medisch Centrum0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age of 18 years or older
  • - Scheduled for total hip replacement surgery under neuraxial surgery
  • - Scheduled for primary hip replacement surgery
  • - Informed consent obtained

排除标准

  • - Insufficient control of the Dutch language to read the patient information
  • and to fill out de questionnaires
  • - Mentally incapcitated patients
  • - Known or suspected hypersensitivity to sugammadex
  • - Deficiency of vitamin K dependent clotting factors or coagulopathy
  • - Severe renal disease (creatinine clearance <30 ml/min), including patients
  • on dialysis)
  • - Severe liver disease (Child-Pugh Classification C)
  • - Women who are or may be pregnant or currently breastfeeding
  • - Women of childbearing potential who don't use adequate method of contraception
  • - Severe vertebral column disorder
  • - Chronic use of psychotropic drugs
  • - Known hypertrophic obstructive cardiomyopathy, severe aortic valve stenosis
  • or severe mitral valve stenosis
  • - Chronic use of NSAID's, steroids or immunosuppressive drugs

研究者

相似试验